ARTELO BIOSCIENCES, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $5.4M | $6.0M | $5.7M | $4.3M | $3.8M | $1.9M | $1.1M |
| SG&A Expense | — | $6.0M | $4.1M | $4.2M | $6.0M | $5.6M | $2.8M | $952.3K |
| Operating Income | — | $-11.4M | $-10.1M | $-9.9M | $-10.3M | $-9.4M | $-4.7M | $-3.2M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | $194.0K | $0 | $0 | $5.0K | $0 | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | — | $-12.9M | $-9.8M | $-9.3M | $-10.1M | $-9.4M | $-4.7M | $-2.2M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | $-0.40 | $-1.26 | $-1.00 |
| EPS (Diluted) | — | $-12.52 | $-18.30 | $-3.14 | — | $-0.40 | $-1.26 | $-1.46 |
| Shares Outstanding (Basic) | 2.1M | — | — | — | 2.9M | 2.8M | 15.1M | 2.2M |
| Shares Outstanding (Diluted) | 2.1M | 1.0M | 537.0K | 3.0M | 2.9M | 2.8M | 15.1M | 2.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |